智通财经APP讯,先健科技(01302)发布公告,本集团的LAmbre Plus左心耳封堵系统(LAmbre Plus或“该器械”)的一项临床试验(该试验),已于2025年3月19日获得美国医保覆盖。该试验由本公司发起,且全部患者入组将会获得医保覆盖。该试验旨在通过与市售经导管LAAO对照器械进行随机对比,证明 LAmbre Plus在降低非瓣膜性房颤患者血栓栓塞风险方面的安全性和有效性。该试验为...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.